Chen et al. (2019) demonstrated that DUXAP8 and DUXAP9 were significantly upregulated in renal cell carcinoma, promoted tumor growth and served as two unfavorable prognostic biomarkers for patients with renal cell carcinoma. The gene discussed is DUXAP9; the disease is hereditary clear cell renal cell carcinoma.